WallStSmart

AMREP Corporation (AXR)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 22101% more annual revenue ($11.77B vs $53.00M). AXR leads profitability with a 24.4% profit margin vs 12.0%. AXR appears more attractively valued with a PEG of 1.55. AXR earns a higher WallStSmart Score of 71/100 (B).

AXR

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 8.0Quality: 9.0
Piotroski: 5/9Altman Z: 14.74

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AXRUndervalued (+65.6%)

Margin of Safety

+65.6%

Fair Value

$68.43

Current Price

$27.68

$40.75 discount

UndervaluedFair: $68.43Overvalued
WELLSignificantly Overvalued (-58.0%)

Margin of Safety

-58.0%

Fair Value

$131.57

Current Price

$212.09

$80.52 premium

UndervaluedFair: $131.57Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AXR6 strengths · Avg: 10.0/10
P/E RatioValuation
11.6x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
93.8%10/10

Revenue surging 93.8% year-over-year

EPS GrowthGrowth
346.2%10/10

Earnings expanding 346.2% YoY

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
14.7410/10

Safe zone — low bankruptcy risk

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
162.6%10/10

Earnings expanding 162.6% YoY

Market CapQuality
$153.42B9/10

Large-cap with strong market position

Areas to Watch

AXR2 concerns · Avg: 3.5/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

Market CapQuality
$148.17M3/10

Smaller company, higher risk/reward

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

PEG RatioValuation
3.662/10

Expensive relative to growth rate

P/E RatioValuation
105.5x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AXR

The strongest argument for AXR centers on P/E Ratio, Price/Book, Revenue Growth. Profitability is solid with margins at 24.4% and operating margin at 20.6%. Revenue growth of 93.8% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : AXR

The primary concerns for AXR are PEG Ratio, Market Cap.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.5x leaves little room for execution misses.

Key Dynamics to Monitor

AXR carries more volatility with a beta of 1.24 — expect wider price swings.

AXR is growing revenue faster at 93.8% — sustainability is the question.

WELL generates stronger free cash flow (647M), providing more financial flexibility.

Monitor REAL ESTATE - DEVELOPMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AXR scores higher overall (71/100 vs 57/100), backed by strong 24.4% margins and 93.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

AMREP Corporation

REAL ESTATE · REAL ESTATE - DEVELOPMENT · USA

AMREP Corporation is primarily engaged in the real estate business. The company is headquartered in Plymouth Meeting, Pennsylvania.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?